88 related articles for article (PubMed ID: 3071424)
1. New human renin inhibitory peptides: angiotensinogen transition-state analogues containing novel Leu-Val replacement and a retro-inverso amide bond.
Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Shimaoka I; Umeyama H; Kiso Y
Chem Pharm Bull (Tokyo); 1988 Jun; 36(6):2278-81. PubMed ID: 3071424
[No Abstract] [Full Text] [Related]
2. Synthesis of human renin inhibitory peptides, angiotensinogen transition-state analogs containing a retro-inverso amide bond.
Harada H; Iizuka K; Kamijo T; Akahane K; Yamamoto R; Nakano Y; Tsubaki A; Kubota T; Shimaoka I; Umeyama H
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3042-7. PubMed ID: 2085885
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site.
Smith CW; Saneii HH; Sawyer TK; Pals DT; Scahill TA; Kamdar BV; Lawson JA
J Med Chem; 1988 Jul; 31(7):1377-82. PubMed ID: 3290486
[TBL] [Abstract][Full Text] [Related]
4. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.
Luly JR; BaMaung N; Soderquist J; Fung AK; Stein H; Kleinert HD; Marcotte PA; Egan DA; Bopp B; Merits I
J Med Chem; 1988 Dec; 31(12):2264-76. PubMed ID: 3143009
[TBL] [Abstract][Full Text] [Related]
5. New inhibitors of human renin that contain novel Leu-Val replacements.
Luly JR; Yi N; Soderquist J; Stein H; Cohen J; Perun TJ; Plattner JJ
J Med Chem; 1987 Sep; 30(9):1609-16. PubMed ID: 3305946
[TBL] [Abstract][Full Text] [Related]
6. Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.
Bolis G; Fung AK; Greer J; Kleinert HD; Marcotte PA; Perun TJ; Plattner JJ; Stein HH
J Med Chem; 1987 Oct; 30(10):1729-37. PubMed ID: 3309313
[TBL] [Abstract][Full Text] [Related]
7. New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site.
Luly JR; Bolis G; BaMaung N; Soderquist J; Dellaria JF; Stein H; Cohen J; Perun TJ; Greer J; Plattner JJ
J Med Chem; 1988 Mar; 31(3):532-9. PubMed ID: 3279206
[TBL] [Abstract][Full Text] [Related]
8. Novel renin inhibitors containing analogues of statine retro-inverted at the C-termini: specificity at the P2 histidine site.
Rosenberg SH; Plattner JJ; Woods KW; Stein HH; Marcotte PA; Cohen J; Perun TJ
J Med Chem; 1987 Jul; 30(7):1224-8. PubMed ID: 3298652
[TBL] [Abstract][Full Text] [Related]
9. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
Allen MC; Fuhrer W; Tuck B; Wade R; Wood JM
J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
[TBL] [Abstract][Full Text] [Related]
10. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
TenBrink RE; Pals DT; Harris DW; Johnson GA
J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
[TBL] [Abstract][Full Text] [Related]
11. Modified peptides which display potent and specific inhibition of human renin.
Luly JR; Plattner JJ; Stein H; Yi N; Soderquist J; Marcotte PA; Kleinert HD; Perun TJ
Biochem Biophys Res Commun; 1987 Feb; 143(1):44-51. PubMed ID: 3548726
[TBL] [Abstract][Full Text] [Related]
12. Renin inhibitors. Design of angiotensinogen transition-state analogues containing novel. (2R,3R,4R,5S)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid.
Thaisrivongs S; Pals DT; Kroll LT; Turner SR; Han FS
J Med Chem; 1987 Jun; 30(6):976-82. PubMed ID: 3295239
[TBL] [Abstract][Full Text] [Related]
13. Renin inhibitors. Improvements in the stability and biological activity of small peptides containing novel Leu-Val replacements.
Kleinert HD; Luly JR; Marcotte PA; Perun TJ; Plattner JJ; Stein H
FEBS Lett; 1988 Mar; 230(1-2):38-42. PubMed ID: 3280345
[TBL] [Abstract][Full Text] [Related]
14. Renin inhibitors. Substitution of the leucyl residues of Leu-Leu-Val-Phe-OCH3 with 3-amino-2-hydroxy-5-methylhexanoic acid.
Johnson RL
J Med Chem; 1982 May; 25(5):605-10. PubMed ID: 7045370
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of renin by angiotensinogen peptide fragments containing the hydroxy amino acid residue 5-amino-3-hydroxy-7-methyloctanoic acid.
Johnson RL; Verschoor K
J Med Chem; 1983 Oct; 26(10):1457-62. PubMed ID: 6352942
[TBL] [Abstract][Full Text] [Related]
16. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability.
Plattner JJ; Marcotte PA; Kleinert HD; Stein HH; Greer J; Bolis G; Fung AK; Bopp BA; Luly JR; Sham HL
J Med Chem; 1988 Dec; 31(12):2277-88. PubMed ID: 3143010
[TBL] [Abstract][Full Text] [Related]
17. Intramolecularly quenched fluorogenic peptide substrates for human renin.
Oliveira MC; Hirata IY; Chagas JR; Boschcov P; Gomes RA; Figueiredo AF; Juliano L
Anal Biochem; 1992 May; 203(1):39-46. PubMed ID: 1524216
[TBL] [Abstract][Full Text] [Related]
18. Potent renin inhibitory peptides containing hydrophilic end groups.
Bundy GL; Pals DT; Lawson JA; Couch SJ; Lipton MF; Mauragis MA
J Med Chem; 1990 Aug; 33(8):2276-83. PubMed ID: 2197413
[TBL] [Abstract][Full Text] [Related]
19. Conformational aspects of angiotensinogen analogues with renin inhibitory activity.
Liepina I; Nikiforovich GV; Paiva AC
Biochem Biophys Res Commun; 1984 Jul; 122(2):700-5. PubMed ID: 6380499
[TBL] [Abstract][Full Text] [Related]
20. Conformationally constrained renin inhibitory peptides: gamma-lactam-bridged dipeptide isostere as conformational restriction.
Thaisrivongs S; Pals DT; Turner SR; Kroll LT
J Med Chem; 1988 Jul; 31(7):1369-76. PubMed ID: 3290485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
